Blue Owl Capital Holdings
$658M 13F equity value
83 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Blue Owl Capital Holdings covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| SPCX | SPACE EXPLORATION TECHN CORP | 1,398,815 | $239M | 36.3% |
| AKTS | AKTIS ONCOLOGY INC | 3,070,219 | $99M | 15.0% |
| CGEM | CULLINAN THERAPEUTICS INC | 1,539,764 | $28M | 4.3% |
| LRMR | LARIMAR THERAPEUTICS INC | 9,163,157 | $28M | 4.2% |
| NCDL | NUVEEN CHURCHILL DIRECT LEND | 2,143,626 | $27M | 4.0% |
| MPLT | MAPLIGHT THERAPEUTICS INC | 729,929 | $26M | 4.0% |
| COF | CAPITAL ONE FINL CORP | 119,757 | $24M | 3.7% |
| OBDC | BLUE OWL CAPITAL CORPORATION | 2,045,070 | $22M | 3.4% |
| FISN | DEEP FISSION INC | 1,333,333 | $15M | 2.2% |
| DELL | DELL TECHNOLOGIES INC | 32,961 | $14M | 2.2% |
Track Blue Owl Capital Holdings's 13F portfolio: $658M in reported holdings, 83 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}